168 related articles for article (PubMed ID: 38238320)
21. Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression.
Kim HY; Yoo YH
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012166
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor EB inhibits non-alcoholic fatty liver disease through fibroblast growth factor 21.
Gong Q; Zhang X; Sun Y; Shen J; Li X; Xue C; Liu Z
J Mol Med (Berl); 2022 Nov; 100(11):1587-1597. PubMed ID: 36102936
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of fibroblast growth factor 21 in non-alcoholic fatty liver disease in guinea pigs.
Klaebel JH; Lykkesfeldt J; Tveden-Nyborg P
Basic Clin Pharmacol Toxicol; 2022 Mar; 130(3):385-393. PubMed ID: 35014168
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet.
Hao L; Huang KH; Ito K; Sae-Tan S; Lambert JD; Ross AC
J Nutr; 2016 Feb; 146(2):184-90. PubMed ID: 26764334
[TBL] [Abstract][Full Text] [Related]
25. Regeneration of Non-Alcoholic Fatty Liver Cells Using Chimeric FGF21/HGFR: A Novel Therapeutic Approach.
Kim SJ; Kim SJ; Hyun J; Kim HW; Jang JH
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542065
[TBL] [Abstract][Full Text] [Related]
26. Coffee peel extracts ameliorate non-alcoholic fatty liver disease
Fan Z; Wang C; Yang T; Gao T; Wang D; Zhao X; Guo X; Li D
Food Funct; 2022 Jul; 13(13):7251-7259. PubMed ID: 35723052
[TBL] [Abstract][Full Text] [Related]
27. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
[TBL] [Abstract][Full Text] [Related]
28. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ
Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301
[TBL] [Abstract][Full Text] [Related]
29. Lack of FGF21 promotes NASH-HCC transition
Zheng Q; Martin RC; Shi X; Pandit H; Yu Y; Liu X; Guo W; Tan M; Bai O; Meng X; Li Y
Theranostics; 2020; 10(22):9923-9936. PubMed ID: 32929325
[No Abstract] [Full Text] [Related]
30. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease.
Waluga M; Kukla M; Zorniak M; Kajor M; Liszka L; Dyaczynski M; Kowalski G; Zadlo D; Waluga E; Olczyk P; Buldak RJ; Berdowska A; Hartleb M
J Physiol Pharmacol; 2017 Jun; 68(3):363-374. PubMed ID: 28820393
[TBL] [Abstract][Full Text] [Related]
32. Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge.
Liu D; Pang J; Shao W; Gu J; Zeng Y; He HH; Ling W; Qian X; Jin T
Hepatology; 2021 Oct; 74(4):2154-2169. PubMed ID: 33851458
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.
Jiang S; Yan C; Fang QC; Shao ML; Zhang YL; Liu Y; Deng YP; Shan B; Liu JQ; Li HT; Yang L; Zhou J; Dai Z; Liu Y; Jia WP
J Biol Chem; 2014 Oct; 289(43):29751-65. PubMed ID: 25170079
[TBL] [Abstract][Full Text] [Related]
34. Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.
Zarei M; Pujol E; Quesada-López T; Villarroya F; Barroso E; Vázquez S; Pizarro-Delgado J; Palomer X; Vázquez-Carrera M
Br J Pharmacol; 2019 Jul; 176(13):2292-2305. PubMed ID: 30927369
[TBL] [Abstract][Full Text] [Related]
35. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
36. Concentrated fish oil ameliorates non-alcoholic fatty liver disease by regulating fibroblast growth factor 21-adiponectin axis.
Guo XF; Wang C; Yang T; Ma WJ; Zhai J; Zhao T; Xu TC; Li J; Liu H; Sinclair AJ; Li D
Nutrition; 2022; 99-100():111659. PubMed ID: 35594631
[TBL] [Abstract][Full Text] [Related]
37. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.
Liu Q; Liu Y; Li F; Gu Z; Liu M; Shao T; Zhang L; Zhou G; Pan C; He L; Cai J; Zhang X; Barve S; McClain CJ; Chen Y; Feng W
J Nutr Biochem; 2020 Jan; 75():108256. PubMed ID: 31760308
[TBL] [Abstract][Full Text] [Related]
38. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease.
Su X; Kong Y; Peng D
Clin Chim Acta; 2019 Nov; 498():30-37. PubMed ID: 31419414
[TBL] [Abstract][Full Text] [Related]
40. Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis.
Chen S; Chen D; Yang H; Wang X; Wang J; Xu C
BMC Gastroenterol; 2020 Feb; 20(1):39. PubMed ID: 32070295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
